1Gao YH, Zhou SF, Wen JB, et al. Mechanism of the antiulcerogenic effect of Ganoderma lucidum polysaccharides on indomethacin-induced lesions in the rat. Life Sci, 2002, 72:731-745.
2You YH, Lin ZB. Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species. Acta Pharmacol Sin, 2002, 23:787-791.
3Lin JM, Lin CC, Chen MF, et al. Radical scavenger and antihepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neo-japonicum. J Ethnopharmacol, 1995, 47:33-34.
4Joshph L, Stephen L, eds. Diabetes research. Vol I: laboratary methods. New York: John Wiley Inc. 1985. 310-313.
5Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976;72:248-254.
6Orci L, Unger R, Ravazzola M, et al. Reduced β-cell glucose transporter in new onset diabetic BB rats. J Clin Invest, 1990,86:1615-1622.
7Reddy S, Young M, Poole CA, et al. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low- dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscope. Gen Comp Endocrinol, 1998, 111:9-19.
8Wang ZY, Gleichmann H. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes, 1998,47:50-56.
